Cingulate

CING · NASDAQ

$4.53+$0.17 (+3.90%)TodayMarket closed ·
Prev close $4.36

Latest news

  • Press releaseGlobe Newswire

    Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

  • Press releaseGlobe Newswire

    Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

  • Press releaseGlobe Newswire

    Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile

  • Press releaseGlobe Newswire

    Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

  • Press releaseGlobe Newswire

    Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

  • Press releaseGlobe Newswire

    Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Cingulate Receives Complete Response Letter from FDA for CTx-1301

  • Press releaseGlobe Newswire

    Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsNabaparna Bhattacharya

    What's Going On With Cingulate Stock Today?

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

  • Press releasePRNewswire

    Life365 Appoints Healthcare Veteran Jay Roberts as Chief Development Officer

  • NewsChris Katje

    EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsVaishali Prayag

    What's Going On With Cingulate Shares Recently?

  • News

    Watching Cingulate; Zacks Small-Cap Research Gives stock $70 Price Valuation

  • NewsAvi Kapoor

    Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Nasdaq Surges 150 Points; Sonder Holdings Shares Surge

  • NewsAvi Kapoor

    Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

  • NewsAvi Kapoor

    Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Crude Oil Down 2%; Zoomcar Shares Spike Higher

  • NewsAvi Kapoor

    Dow Jumps 75 Points; US Consumer Confidence Surges In August

  • NewsChris Katje

    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

  • NewsAvi Kapoor

    US Stocks Edge Lower; Applied Materials Earnings Top Views

  • News

    Top 5 Trending Stocks Of The Day: Amazon, AST Spacemobile, Cingulate, Applied Materials, And Tesla

  • NewsVaishali Prayag

    What's Going On With Cingulate Shares Today?

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue

  • NewsAvi Kapoor

    Nasdaq Jumps Over 2%; Walmart Earnings Top Views

  • NewsAvi Kapoor

    Dow Surges Over 500 Points; US Retail Sales Rise In July

  • News

    Market-Moving News for August 15th

  • NewsAvi Kapoor

    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

  • NewsAvi Kapoor

    US Stocks Edge Higher; Inflation Slows To 3% In June

  • NewsAvi Kapoor

    Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.